Critical Care Medicine 52(11):p
1661-1673, November 2024.
OBJECTIVE:
To determine the impact of point-of-care ultrasound
(POCUS)-guided resuscitation on clinical outcomes in adult patients with shock.
DATA SOURCE:
We searched MEDLINE, Embase, and unpublished sources from
inception to December 2023.
STUDY SELECTION:
We included randomized controlled trials (RCTs) that
examined the use of POCUS to guide resuscitation in patients with shock.
DATA EXTRACTION:
We collected data regarding study and patient
characteristics, POCUS protocol, control group interventions, and outcomes.
DATA SYNTHESIS:
We identified 18 eligible RCTs. POCUS slightly influences
physicians’ plans for IV fluid (IVF) and vasoactive medication prescription
(moderate certainty), but results in little to no changes in the administration
of IVF (low to high certainty) or inotropes (high certainty). POCUS may result
in no change in the number of CT scans performed (low certainty) but probably
reduces the number of diagnostic echocardiograms performed (moderate
certainty). POCUS-guided resuscitation probably reduces 28-day mortality
(relative risk [RR] 0.88; 95% CI, 0.78–0.99), the duration of vasoactive
medication (mean difference –0.73 d; 95% CI, –1.16 to –0.30), and the need for
renal replacement therapy (RRT) (RR 0.80; 95% CI, 0.63–1.02) (low to moderate
certainty evidence), and lactate clearance (high certainty evidence).
POCUS-guided resuscitation may results in little to no difference in ICU or
hospital admissions, ICU and hospital length of stay, and the need for
mechanical ventilation (MV) (low to moderate certainty evidence). There is an
uncertain effect on the risk of acute kidney injury and the duration of MV or
RRT (very low certainty evidence).
CONCLUSIONS:
POCUS-guided resuscitation in shock may yield important
patient and health system benefits. Due to lack of sufficient evidence, we were
unable to explore how the thresholds of operator competency, frequency, and
timing of POCUS scans impact patient outcomes.
No comments:
Post a Comment